What is the reason why Daewoong Pharmaceutical was interested in Hanall Biopharma, followed by Yuhan Corporation?
Followed by Yuhan Corporation which purchased 8.95% of the Hanall Biopharma’s total shares three years ago, Daewoong Pharmaceutical attracted interests of the industry as buying 30.2% of its total shares.
On the 29th, Daewoong Pharmaceutical invested KRW 104.6 billion funds to secure the total 1...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
